NW, E., Y, H., Y, Z., J, W., L, S., DW, C., . . . VM, N. (2026). Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2: ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer. JU open plus, 4(2), e00019. https://doi.org/10.1097/JU9.0000000000000425
Chicago Style (17th ed.) CitationNW, Eyrich, et al. "Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2: ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer." JU Open Plus 4, no. 2 (2026): e00019. https://doi.org/10.1097/JU9.0000000000000425.
MLA (9th ed.) CitationNW, Eyrich, et al. "Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2: ERG RNA Testing Improves Detection of Clinically Significant Prostate Cancer." JU Open Plus, vol. 4, no. 2, 2026, p. e00019, https://doi.org/10.1097/JU9.0000000000000425.